New copper-catalyzed C-H activation strategy from Scripps Research
LA JOLLA, CA — Inspired by what human liver enzymes can do, Scripps Research chemists have developed a new set of copper-catalyzed organic synthesis reactions for building and modifying pharmaceuticals and other molecules. The new reactions are expected to be widely used in drug discovery and optimization, as well as in other chemistry-based industries. In their study, which initially published in an unedited version on March 28, 2024, in Nature, the chemists showed that their new methods can be used to